Probenecid as Medication for Alcohol Use Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The design is a randomized, within-subject, crossover, double-blind, placebo-controlled human alcohol laboratory study with one oral dose of 2g probenecid or placebo administered in two laboratory sessions.
Epistemonikos ID: 012a651422b3726cac84ef815a286f77885ad151
First added on: May 06, 2024